Annexin Pharmaceuticals Stock Forward View - Simple Moving Average
| ANNX Stock | SEK 14.70 0.30 2.08% |
Momentum 43
Sell Extended
Oversold | Overbought |
This section frames Annexin Pharmaceuticals AB response to recent headlines in a peer context.
The Simple Moving Average forecasted value of Annexin Pharmaceuticals AB on the next trading day is expected to be 14.55 with a mean absolute deviation of 0.80 and the sum of the absolute errors of 47.20.Annexin Pharmaceuticals after-hype prediction price | SEK 14.4 |
This view helps relate attention signals to forecasting and technical indicators plus earnings context.
Annexin |
Annexin Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Annexin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Annexin using various technical indicators. When you analyze Annexin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Annexin Pharmaceuticals Simple Moving Average Price Forecast For the 11th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Annexin Pharmaceuticals AB on the next trading day is expected to be 14.55 with a mean absolute deviation of 0.80 , mean absolute percentage error of 1.59 , and the sum of the absolute errors of 47.20 .Please note that although there have been many attempts to predict Annexin Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Annexin Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Annexin Pharmaceuticals Stock Forecast Pattern
| Backtest Annexin Pharmaceuticals | Annexin Pharmaceuticals Price Prediction | Research Analysis |
Annexin Pharmaceuticals Forecasted Value
This next-day forecast for Annexin Pharmaceuticals AB uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Annexin Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Annexin Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.9011 |
| Bias | Arithmetic mean of the errors | 0.2017 |
| MAD | Mean absolute deviation | 0.8 |
| MAPE | Mean absolute percentage error | 0.0454 |
| SAE | Sum of the absolute errors | 47.2 |
The degree to which Annexin Pharmaceuticals' exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
Annexin Pharmaceuticals After-Hype Price Density Analysis
The after-hype price distribution for Annexin Pharmaceuticals helps investors understand how much of Annexin Pharmaceuticals' predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for Annexin Pharmaceuticals are inherently more speculative.
Next price density |
| Expected price to next headline |
Annexin Pharmaceuticals Estimiated After-Hype Price Volatility
Historical news patterns for Annexin Pharmaceuticals reveal how the market has historically digested different types of information about Annexin Pharmaceuticals' business and market environment. Annexin Pharmaceuticals' after-hype downside and upside margins for the prediction period are 7.36 and 21.44, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
The after-hype framework applied to Annexin Pharmaceuticals AB assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Annexin Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Annexin Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Annexin Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Annexin Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 6.99 | 0.00 | 0.00 | 0 Events | 0 Events | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
14.70 | 14.40 | 0.00 |
|
Annexin Pharmaceuticals Hype Timeline
Annexin Pharmaceuticals is presently traded for 14.70on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Annexin is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.47%. %. The volatility of related hype on Annexin Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 14.70. About 45.0% of the company shares are held by company insiders. The book value of Annexin Pharmaceuticals was presently reported as 0.2. The company recorded a loss per share of 0.43. Annexin Pharmaceuticals had not issued any dividends in recent years. The entity completed a 100:1 stock split on 16th of May 2025. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Historical Fundamental Analysis of Annexin Pharmaceuticals provides a cross-check on projections for Annexin Pharmaceuticals. The analysis adds historical context for the projection set.Annexin Pharmaceuticals Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of Annexin Pharmaceuticals' competitive environment by quantifying the market's sensitivity to news across all major players in Annexin Pharmaceuticals's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ISOFOL | Isofol Medical AB | 0.00 | 0 per month | 0.00 | -0.01 | 2.99 | -4.17 | 50.92 | |
| LIPUM | Lipum AB | 0.00 | 0 per month | 0.00 | -0.07 | 1.75 | -1.69 | 5.07 | |
| INIT | Initiator Pharma AS | 0.00 | 0 per month | 2.61 | 0.01 | 6.47 | -5.63 | 19.49 | |
| IRLAB-A | IRLAB Therapeutics AB | 0.00 | 0 per month | 0.00 | -0.11 | 6.51 | -6.47 | 18.07 | |
| ALZ | Alzinova AB | 0.00 | 0 per month | 0.00 | -0.23 | 4.00 | -5.63 | 54.47 | |
| ERMA | Enorama Pharma AB | 0.00 | 0 per month | 0.00 | -0.03 | 29.41 | -21.05 | 94.69 | |
| CLS-B | Clinical Laserthermia Systems | 0.00 | 0 per month | 0.00 | -0.01 | 7.51 | -7.38 | 51.78 | |
| KDEV | Karolinska Development AB | 0.00 | 0 per month | 0.00 | -0.13 | 11.54 | -13.16 | 47.86 | |
| BIOWKS | Bio Works Technologies AB | 0.00 | 0 per month | 2.76 | 0.11 | 8.89 | -4.50 | 16.66 | |
| INTEG-B | Integrum AB Series | 0.00 | 0 per month | 0.00 | -0.09 | 6.50 | -5.76 | 16.88 |
Other Forecasting Options for Annexin Pharmaceuticals
The price trajectory of Annexin is the primary concern for any investor assessing it as an opportunity. Annexin Stock price charts are filled with noise that can easily mislead uninformed investment decisions.Annexin Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Annexin Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Annexin Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Annexin Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Annexin Pharmaceuticals Market Strength Events
Understanding the market strength of Annexin Pharmaceuticals stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in Annexin Pharmaceuticals AB with greater precision.
Annexin Pharmaceuticals Risk Indicators
Reviewing Annexin Pharmaceuticals' basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding Annexin Pharmaceuticals' and informs decisions about hedging and position.
| Mean Deviation | 4.18 | |||
| Standard Deviation | 6.61 | |||
| Variance | 43.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Annexin Pharmaceuticals
Coverage intensity for Annexin Pharmaceuticals AB matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Annexin Pharmaceuticals Short Properties
Short sentiment tied to Annexin Pharmaceuticals AB matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 92.3 M | |
| Cash And Short Term Investments | 49.5 M |
Additional Tools for Annexin Stock Analysis
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |